Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:Today's share price action is only the beginning...

[4evergreen]

This would be a great fit I think - I'm definitely eager to find out who the partner is. Thanks for sharing Bella!

Bella2017 wrote:
Keep in mind, the unknown partnership is a private company, I'm betting on Apotex, one of the largest in Canada.
 

APOTEX is an independent, dynamic, Canadian pharmaceutical company committed to R&D, manufacturing and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers and governments worldwide. We will always meet global regulatory, quality and compliance requirements. We value and respect our employees, our business partners, our suppliers, our customers and the communities we serve while operating with accountability and integrity in everything we do.

Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company. From its 2 employees, 5,000 square foot beginning, the company has grown to employ over 10,000 people in research, development, manufacturing and distribution facilities world-wide. The Canadian operations of the Apotex Group of Companies has over 6,000 employees. Extensive investments in Canadian facilities include over 3 million square feet in manufacturing and R&D facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year - the largest amount of any pharmaceutical company in this country.

 

Today, Apotex is a necessary and trusted member of Canada's healthcare community. The company's pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe. Export markets represent an ever growing portion of the total sales. Apotex has also established a presence through subsidiaries, joint ventures or licensing agreements in Australia, Belgium, Czech Republic, Mexico, Netherlands, New Zealand and Poland to name just a few. Healthcare professionals around the world rely on Apotex for quality and value.

Although the company's own business is developing and manufacturing generic pharmaceuticals, the success of Apotex has enabled it to diversify into a number of other health-related areas. The Apotex Pharmaceutical Group of Companies also researches, develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use.

The worldwide sales of the Apotex Group of companies exceed $2 billion (Canadian $) per year.

 

 

4evergreen wrote:

International distribution partner - looking good. 

 

LeafRider wrote: For those thinking this news isn't big news, and some thinking this should be easily a dollar today. You both are right in a way. 1st of all this is massive news but only once they announce the king pin they are partnering with. So today is "buy the rumor"... once the news is fully released, that's when you'll see your day traders "sell the news". Doesn't really matter in this case because we're looking at an increase to our forecasted sales and none of this was built into Tetra's share price valuation at a 70 mil market cap.

Now you have International distribution of your entire product line over night. If you don't think that is big news, you're dilutional. These deals don't get done with products that aren't valid, you watch the exposure alone to all the clinics and people involved down the line, they are all going to buying shares of Tetra at some point. 

Think of it this way, if you are a $0.65 company about 70 million in market cap, you have zero distribution at that value. Now you partner with a massive pharmacy that has international connections. Sales will be something that will be generated as part of this deal, and with sales shareholders will see a huge rise in share price. Look at it this way, all your LPs are currently running a deficit and they are all rising in value. Tetra has a chance to be very profitable early on in the process.

So today we could finish in the low 0.80s, but it doesn't really matter where we finish today. It's where the share price will be once PPP001 has a DIN# on top of all this good news, and you know as I do PPP001 will already have a distribution channel established and probably other distribution channels lining up to get a piece of the pie. All the pre-DIN sales will have a valid channel now with this deal, and all the sales numbers you thought you knew are about to change dramatically for Tetra.

Once Tetra is allowed to openly state who they are partnered with, this stock will rise once again from where ever it's at. Who cares if it's Shopper Drug Mart, Walmart, IGA, Pharmasave, etc. It doesn't really matter. Your current product line and your pending product line just established a major international channel for distribution. For me this one deals with PPP003 and PPP004 etc. and everything related to Panag... But there's more...

See description:
Tetra Bio-Pharma and Panag Pharma have a definitive agreement for two products, PPP003 and PPP004 for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion.

Don't forget the "Natural Health Product line" from AgroTek:

 

• Munchies B GONE gum
• AGT001
  Topical product for pain management
• AGT002 product line-oral
  Cardiovascular disease prevention, athletic performance, and well-being
• AGT003 product line
  Topical products for skin care
• AGT004
  Topical for women – quality of life